Icon

CEPTAZ (nda050646)- (1GM/VIAL,2GM/VIAL,10GM/VIAL,500MG/VIAL)

CEFTAZIDIME GLAXOSMITHKLINE
1GM/VIAL,2GM/VIAL,10GM/VIAL,500MG/VIAL
No No
Expired Expired
None None
None No
CEPTAZ is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: Lower Respiratory Tract Infections, Skin and Skin-Structure Infections, Urinary Tract Infections, Bacterial Septicemia, Bone and Joint Infections, Gynecologic Infections, Intra-abdominal Infections, Central Nervous System Infections.
0 0 0
Total Other Developers None
Drugs with Suitability No
1GM/VIAL ** ** - - -
2GM/VIAL ** ** - - -
10GM/VIAL ** ** - - -
500MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.